REFERENCES
- von Willebrand EA. Heriditär pseudohemofili. Finska Läkarsällskapets Handlingar 1926; 69: 87–112.
- Mazurier C, Ribba AS, Gaucher C, Meyer D. Molecular genetics of von Willebrand disease. Ann Genet 1998; 41: 34–43.
- Ruggeri ZM. Structure and function of von Willebrand factor: relationship to von Willebrand's disease. Mayo Clin Proc 1991; 66: 847–61.
- Howard MA, Firkin BG. Ristocetin: a new tool in the investigation of platelet aggregation. Thromb Diath Haemorrh 1971; 26: 362–9.
- Kao K-J, Pizzo SV, McKnee PA. Platelet receptors for human factor VIII/von Willebrand protein: functional correlation of receptor occu-pancy and ristocetin-induced platelet aggregation. Proc Natl Acad Sci USA 1979; 76: 5317–20.
- Frojmovic MM. Platelet aggregation in flow: differential roles for adhesive receptors and ligands. Am Heart J 1998; 135: S119–31.
- Veyradier A, Fressinaud E, Meyer D. Laboratory diagnosis of von Willebrand's disease. Int J Clin Lab Res 1998; 28: 201–10.
- Lindahl TL, Festin R, Larsson A. Studies of fibrinogen binding to platelets by flow cytometry: an improved method for measuring platelet activation. Thromb Haemost 1992; 68: 221–5.
- Allain JP, Copper HA, Wagner RH, Brinkhous KM. Platelets fixed with paraformaldehyde: a new reagent for assay of von Willebrand factor and platelet aggregating factor. J Lab Clin Med 1975; 85: 318–28.
- Holmberg L, Nilsson IM. Genetic variants of von Willebrand's disease. Br Med J 1972; 3: 317–20.
- Rodegheiro F, Castaman G, Dini E. Epidemiolo-gical investigations of the prevalence of von Willebrand's disease. Blood 1987; 69: 454–9.
- Werner EJ, Broxson EH, Tucker EL, Giroux DS, Shults J, Abshire TC. Prevalence of von Willebrand disease in children: a multiethnic study. J Pediatr 1993; 123: 893–8.
- Jaffe EA, Hoyer LW, Nachman RL. Synthesis of antihemophilic factor antigen by cultured human endothelial cells. J Clin Invest 1973; 52: 2757— 64.
- Nachman R, Levine R, Jaffe EA. Synthesis of factor VIII antigen by cultured guinea pig megakaryocytes. J Clin Invest 1977; 60: 914–21.
- Howard MA, Montgomery DC, Hardisty RM Factor VIII-related antigen in platelets Thromb Res 1974; 4: 617–24.
- Tschopp TB, Weiss HJ, Baumgartner HR. Decreased adhesion of platelets to subendothelium in von Willebrand's disease. J Lab Clin Med 1974; 83: 296–300.
- Hoylaerts MF. Platelet-vessel wall interactions in thrombosis and restenosis role of von Willebrand factor. Verh K Acad Geneeskd Belg 1997; 59: 161— 83.
- Murdock PJ, Woodhams BJ, Matthews KB, Pasi JP, Goodall AH. Von Willebrand factor activity detected in a monoclonal antibody-based ELISA: an alternative to the ristocetin cofactor platelet agglutination assay for diagnostic use. Thromb Haemost 1997; 78: 1272–7.
- Preston FE. Assays for von Willebrand factor functional activity: a UK NEQAS survey. National External Quality Assessment Scheme. Thromb Haemost 1998; 80: 863.
- Miller CH, Platt SJ, Daniele C, Kaczor D. Evaluation of two automated methods for measurement of the ristocetin cofactor activity of von Willebrand factor. Thromb Haemost 2002; 88: 56–9.
- Fressinaud E, Veryadier A, Truchaud F, Martin I, Boyer-Neumann C, Trossaert M, Meyer D. Screening for von Willebrand's disease with a new analyzer using high shear stress: a study of 60 cases. Blood 1998; 91: 1325–31.
- Lindahl TL, Larsson A. Clq binding to platelets induced by monoclonal antibodies and immune complexes—a flow cytometric analysis. Platelets 1993; 4: 73–7.